USPTO serial 79406972
ARTIFICIAL CLINICAL INTELLIGENCE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- FRUM MILONE, MARCIE R
- Law office
- TMO LAW OFFICE 116
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ARTIFICIAL CLINICAL INTELLIGENCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Clinical decision support software and application; computer assisted medical interventions information database recorded on computer media; computer software and software applications for accessing medical and health information; downloadable computer software for analyzing molecular and clinical data for research in the fields of medicine; downloadable podcasts in the field of healthcare, medicine, public health, infectious diseases, and medical conditions; downloadable web application software for use in search and reference of medical conditions for medical diagnostic services; electronic medical publications; software applications for mobile devices for accessing medical and health information. | SECTION 70 - CANCELLED | — |
| 035 | Analysis of market research data and statistics; business consultancy in the field of pharmaceutical leads; business management; business management advice; business management analysis; business management and administration; business management and advice; business research services; collection of market research information; collection of medical reports; compilation of statistical data for use in scientific or medical research; computerised market research services; computerized market research services; conducting business and market research services for others; interpretation of market research data; market analysis and research; market analysis and research services; market analysis and studies; market assessment services; market reports and studies; market research by means of a computer database; market research consultancy; market research services; market research studies; market studies; market study and analysis of market studies; marketing research; marketing research and analysis services; providing information about market analysis and research services; providing information about market research; providing market research information; providing marketing leads for the pharmaceutical industry; providing sales leads for the pharmaceutical industry; provision of market research information; statistical analysis and reporting services for business purposes; statistical evaluation of market research data. | SECTION 70 - CANCELLED | — |
| 042 | Advisory services in the field of pharmacology; analysis of proteins for scientific and medical research purposes; analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; application service provider featuring application programming interface (API) software for analyzing molecular and clinical data for scientific and medical research; biological therapeutic research services; biomedical research; biomedical research services; chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries; computer diagnostic services for pharmacists and healthcare practitioners; computer programming in the medical field; conducting early evaluations in the field of new pharmaceuticals; conducting research, development, and evaluations in the field of new pharmaceuticals; consultancy pertaining to pharmacology; consultancy services by physicians and medical researchers in the field of virtual reality software development for use in medical, healthcare and surgical training; consulting services in the field of pharmaceutical research; design and development of virtual reality software for use in providing online collaboration environments between medical professionals; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals and nutraceuticals; maintaining and hosting databases on a global computer network for collecting and sharing results of simulated medical interventions; medical and pharmacological research services; medical research; medical research information in the fields of pharmaceuticals; medical research services; pharmaceutical drug development services; pharmaceutical evaluation services; pharmaceutical product evaluation; pharmaceutical research and development; pharmaceutical research services; pharmacological research services; platform as a service (PaaS) for searching structured and unstructured data for healthcare data analytics; platform as a service (PaaS) provider for optimizing healthcare pricing and payments; providing information about medical research; providing information relating to medical research in the field of pharmacovigilance; providing medical and scientific research information in the field of cosmetics and clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and proteomics; providing medical research information in the field of clinical trials; providing non-downloadable computer software for use in quality assurance of the services of others in the field of pharmaceuticals and medical devices; providing online non-downloadable computer software for interpreting, displaying, managing, and sharing healthcare information, namely, test results from in vitro diagnostic devices; providing scientific research information in the fields of pharmaceuticals; providing temporary use of non-downloadable software for accessing databases in connection with research and development services in the fields of medicine; providing temporary use of non-downloadable software for accessing information for use in connection with research and development services in the fields of medicine; research and analysis in the field of medicine; research and development in the pharmaceutical and proteomics fields; research and development of vaccines and medicines; research in the field of artificial intelligence technology; research in the fields of clinical trials and post-market trials; research on the subject of pharmaceuticals; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry; scientific research services in the field of pharmacovigilance; software as a service (saas) provided for accessing medical and health information; technical consulting in the field of artificial intelligence; testing of new products for others; testing of pharmaceuticals; testing, inspection and research of pharmaceuticals, cosmetics and foodstuffs. | SECTION 70 - CANCELLED | — |
| 044 | Evaluation of clinical effectiveness for others; health care consultancy in the fields of public health, health assessments, and medical clinic services; information, advisory and consultancy services in the field of medical care and analysis services; information, advisory and consultancy services in the field of medical clinic services; information, advisory and consultancy services in the field of medical treatment services. | SECTION 70 - CANCELLED | — |
| 045 | Regulatory compliance consultancy in the field of clinical trials; regulatory compliance consultancy in the field of medical biotechnology. | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Loon Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named ARTIFICIAL CLINICAL INTELLIGENCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 4, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 2, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 16, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 16, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 4, 2025 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 4, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 7, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 22, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 22, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 27, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 26, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 29, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 18, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 17, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |